Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2022-09-10 2022-09-09
Drug Identification Number 02303108 02303108
Brand name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Common or Proper name HEPARIN NA HEPARIN NA
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients HEPARIN SODIUM HEPARIN SODIUM
Strength(s) 10000UNIT 10000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5ML 10LIVI 5ML 10LIVI
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-09 2022-09-09
Estimated end date 2022-09-16 2022-09-16
Actual end date 2022-09-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments